Multi-Cancer Screening Tests: Communicating About Risks Should be Prioritized

Am J Med. 2022 Apr;135(4):413-415. doi: 10.1016/j.amjmed.2021.09.012. Epub 2021 Oct 14.

Authors

Timothée Olivier¹, Jenny Gill², Vinay Prasad²

Affiliations

¹ Department of Oncology, Geneva University Hospital, Switzerland. Electronic address: timothee.olivier@hcuge.ch.
² Department of Epidemiology and Biostatistics, University of California San Francisco, Calif.

PMID: 34655543
DOI: 10.1016/j.amjmed.2021.09.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Early Detection of Cancer* / adverse effects
Humans
Mass Screening
Neoplasms* / diagnosis